Donor versus recipient: Neointimal cell origin in allograft vascular disease

Graft

Volumn 5, Issue 7, 2002, Pages 390-398

  Skaro, Anton I ^b   Liwski, Robert S ^b   Johnson, Paul ^b   Legare, Jean Francois ^b   Lee, Timothy D G ^b   Hirsch, Gregory M ^a  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; FEMALE; GRAFT REJECTION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNE INJURY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; MALE; MESENCHYME CELL; MOUSE; NONHUMAN; ORGAN DONOR; POLYMERASE CHAIN REACTION; RAT; RECIPIENT; REVIEW; STEM CELL; TREATMENT FAILURE; TUNICA MEDIA; VASCULAR DISEASE;

EID: 18744402998     PISSN: 15221628     EISSN: None     Source Type: Journal    
DOI: 10.1177/152216202237626     Document Type: Review

References (28)

1. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: eighteenth official report-2001. J Head Lung Transplant 2001;20:805-15.
2. Hayry P, Isoniemi H, Yilmaz S, Mennander A, Lemstrom K, Raisanen-Sokolowski A, et al. Chronic allograft rejection. Immunol Rev 1993;134:3381.
3. Azuma H, Nadeau K, Mackenzie HS, Brenner EM, Tilney NL. Nephron mass modulates the hemodynamic, cellular, and molecular response of the rat renal allograft. Transplantation 1997;63:519-28.
4. Kennedy LJ Jr, Weissman IL. Dual origin of intimal cells in cardiac-allograft arteriosclerosis. N Engl J Med 1971;285:884-7.
5. Shirwan A. Chronic allograft rejection: do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation 1999;68:715-26.
6. Akyurek LM, Paul LC, Funa K, Larsson E. Fellstrom BC. Smooth muscle cell migration into intima and adventitia during development of transplant vasculopathy. Transplantation 1996;62:1526-9.
7. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-9.
8. Libby P. Changing concepts in atherogenesis. J Int Med 2000;247:349-58.
9. Orosz CG, Pelletier RP. Chronic remodelling pathology in grafts. Curr Opin Immunol 1997;9:676-80.
10. Bojakowski K, Religa P, Bojakowska M, Hedin U, Gaciong Z, Thyberg J. Arteriosclerosis in rat aortic allografts: early changes in endothelial integrity and smooth muscle phenotype. Transplantation 2000;70(1):65-72.
11. Han CI, Campbell GR, Campbell GH. Circulating bone marrow cells can contribute to neointimal formation. J Vasc Res 2001;38:113-9.
12. Plissonnier D, Nochy D, Poncet P, Mandet C, Hinglais N, Bariety J, et al. Sequential immunological targeting of chronic experimental arterial allograft. Transplantation 1995;60:414-24.
13. Hirsch GM, Kearsey J, Burt T, Karnovsky MJ, Lee T. Medial smooth muscle cell loss in arterial allografts occurs by cytolytic cell induced apoptosis. Eur J Cardiothorac Surg 1998:14(1):89-96.
14. + T lymphocytes mediate destruction of the vascular media in a model of chronic rejection. Am J Pathol 2000;157:859-65.
15. O'Neill JL, Lee TD, Hirsch GM. CD8+ cytotoxic T lymphocytes are involved in inducing medial cell dropout via apoptosis in mouse aortic allografts. Transplant Proc 1999;31:865-6.
16. Johnson P, Carpenter M, Hirsch GM, Lee TD. Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis. Am J Transpl 2001;2(3):207-214.
17. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis. J Clin Invest 2001;107:1411-22.
18. Li J, Sensebe L, Herve P, Charbord P. Non-transformed colony-derived stromal cell lines from normal human marrows: phenotypic characterization and differentiation pathway. Exp Hematol 1995;23:133-41.
19. Aziz S, McDonald TO. Gohra H. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. J Heart Lung Transpl 1995;14:123-36.
20. Saiura A, Sata M, Hirata Y, Nagai R, Makuuchi M, Circulating smooth muscle progenitor cells contribute to atherosclerosis. Nat Med 2001;7:382-3.
21. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 2000;105:71-7.
22. Wu MH. Shi W, Wechezak AR, Clowes AW, Gordon IL, Sauvage LR, Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J Vasc Surg 1995;21:862-7.
23. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001;7:738-41.
24. Hillebrands JL, Klatter FA, van Dijk WD, Rozing J. Bone marrow does not contribute substantially to endothelial-cell replacement in transplant arteriosclerosis. Nat Med 2002;8:194-5.
25. Bieber CP, Stinson EB, Shumway NE, Payne R, Kosek J. Cardiac transplantation in man. Circulation 1970;41:753-72.
26. Hruban RH, Long PP, Perlman EJ, Hutchins GM, Baumgartner WA, Baughman KL, et al. Fluorescence in situ hybridization for the Y-chromosome can be used to detect cells of recipient origin in allografted hearts following cardiac transplantation. Am J Pathol 1993;142:975-80.
27. Grimm PC, Nickerson P, Jeffery J, Savani RC, Gough J, McKenna RM, et al. Neointimal and tubulointerstitial infiltration by recipient mesenchymal cells in chronic renal-allograft rejection. N Engl J Med 2001;345(2):93-7.
28. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, et al. Chimerism of the transplanted heart. N Engl J Med 2002;346(1):5-15.